RE:RE:RE:Seagen filed SEC Schedule 14A outlining Pfizer $43 Bln M&A " Second requests from the FTC come in roughly 25% of merger and acquisition deals, with the regulator challenging a transaction 5% to 10% of the time, MEDACorp told SVB, adding that a second request can extend the timeline for review by six to nine months.
A month ago, Pfizer revealed in an SEC filing that it had withdrawn its notification for the buyout of Seagen and would refile it later in the day (which hadn't happened as announced). The move extended the FTC’s review of the deal by 30 days to Friday of last week.
The FTC's attempt to block the Amgen-Horizon deal—it's first such move against a biopharma company in more than a decade—raises concern for Pfizer's buyout of Seagen. "
https://www.fiercepharma.com/pharma/ftc-asks-pfizer-seagen-more-information-proposed-43b-merger